|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.25 SEK | +0.83% |
|
+2.54% | +59.55% |
BioInvent International AB announced that the company's Board of Directors has appointed Michael Oredsson as new President and CEO. He will take office within six months. He has for many years held senior executive positions in the pharmaceutical and biotech industry.
He is currently the CEO of Probi AB and has held his earlier executive positions at, among others, Pharmacia Corporation.
| 1st Jan change | Capi. | |
|---|---|---|
| +59.55% | 184M | |
| +9.99% | 115B | |
| +12.01% | 106B | |
| -3.07% | 24.69B | |
| -0.93% | 21.97B | |
| -5.43% | 19.27B | |
| -6.90% | 17.56B | |
| -39.36% | 17.32B | |
| +5.82% | 14.03B | |
| +33.05% | 12.13B |
BIOINVENT INTERNATIONAL AB 
